Phamily Pharma
0865.835.955 · rovalta.com · 24/09/2026
Phamily Pharma
Company — Judicial dissolution or nullity.
Overview
What does Phamily Pharma do?
Phamily Pharma is a Private limited company incorporated in 2004. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Aalst.
9300 Aalst · FlandreSee on map
Joint committees (1)
- 313
Trend over 16 financial years
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||
| Gross margin | -51,3 k € | -356% | 20 k € | +131% | -64,8 k € | -453% | 18,3 k € | -20.0% | 22,9 k € | -59.2% | 56,2 k € | +101% | 27,9 k € | +22.4% | 22,8 k € | -11.2% | 25,7 k € | -43.4% | 45,4 k € | +6.7% | 42,5 k € | -51.8% | 88,3 k € | -2.5% | 90,6 k € | -6.6% | 97 k € | +17.1% | 82,9 k € | -5.8% | 87,9 k € |
| EBITDA | -52,4 k € | -367% | 19,6 k € | +130% | -65,1 k € | -590% | 13,3 k € | -36.2% | 20,8 k € | -60.9% | 53,4 k € | +773% | 6,1 k € | -71.6% | 21,5 k € | -11.8% | 24,4 k € | -44.7% | 44,1 k € | +6.8% | 41,3 k € | -52.6% | 87 k € | -2.5% | 89,3 k € | -6.8% | 95,8 k € | +17.2% | 81,7 k € | -5.9% | 86,9 k € |
| Operating result | -68,2 k € | -3253% | 2,2 k € | +103% | -82,2 k € | -8940% | 929,5 € | -83.0% | 5,5 k € | -85.7% | 38,2 k € | +551% | -8,5 k € | -168% | -3,2 k € | +82.7% | -18,3 k € | -1642% | 1,2 k € | +147% | -2,5 k € | -106% | 44,4 k € | -16.3% | 53,1 k € | -7.2% | 57,2 k € | +35.8% | 42,1 k € | -11.5% | 47,6 k € |
| Net result | -81,1 k € | -12191% | 670,7 € | +101% | -86 k € | -2052% | -4 k € | -2382% | 175,2 € | -99.5% | 34,8 k € | +188% | 12,1 k € | +597% | -2,4 k € | +87.4% | -19,2 k € | -1869% | -976,1 € | +87.5% | -7,8 k € | -121% | 36,4 k € | +13.9% | 32 k € | -8.8% | 35,1 k € | +44.8% | 24,2 k € | -6.2% | 25,8 k € |
| Balance sheet | |||||||||||||||||||||||||||||||
| Equity | -19,2 k € | -131% | 61,9 k € | +1.1% | 61,2 k € | -58.4% | 147,2 k € | -2.6% | 151,2 k € | +0.1% | 151,1 k € | +29.9% | 116,3 k € | +11.6% | 104,2 k € | -2.3% | 106,6 k € | -15.3% | 125,9 k € | -0.8% | 126,8 k € | -5.8% | 134,6 k € | +37.1% | 98,2 k € | -15.5% | 116,3 k € | +43.2% | 81,2 k € | +42.5% | 57 k € |
| Total assets | 409,9 k € | -24.3% | 541,4 k € | +25.8% | 430,2 k € | +14.7% | 375 k € | -14.4% | 438 k € | +2.5% | 427,5 k € | +1.7% | 420,4 k € | +184% | 148,1 k € | -20.4% | 185,9 k € | -22.6% | 240,3 k € | -14.1% | 279,9 k € | -17.1% | 337,7 k € | -7.5% | 365 k € | -5.7% | 386,9 k € | -4.7% | 406 k € | -5.3% | 428,5 k € |
| Cash | 3,9 k € | -58.2% | 9,4 k € | -42.7% | 16,4 k € | +142% | 6,8 k € | -27.4% | 9,4 k € | -0.2% | 9,4 k € | -62.2% | 24,8 k € | -12.4% | 28,4 k € | -31.2% | 41,2 k € | +50.9% | 27,3 k € | +112% | 12,9 k € | -67.7% | 40 k € | +3.8% | 38,5 k € | +52.4% | 25,3 k € | -42.8% | 44,1 k € | +78.7% | 24,7 k € |
| Debts | 362,4 k € | -12.2% | 412,9 k € | +36.5% | 302,4 k € | +87.7% | 161,2 k € | -26.8% | 220,2 k € | -6.5% | 235,6 k € | -3.2% | 243,4 k € | +530% | 38,6 k € | -47.4% | 73,4 k € | -31.7% | 107,5 k € | -26.8% | 146,8 k € | -24.8% | 195,2 k € | -24.4% | 258,2 k € | -1.7% | 262,6 k € | -17.1% | 316,8 k € | -11.8% | 359,2 k € |
Board of directors
Seen on filing of 31/12/2022 · 1 active · 3 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
AFTER DRINKS● Active | 0769.600.968 |
Financials
Full financial information
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 | 01/01/2018 | 01/01/2017 |
| Closing of the financial year | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 | 31/12/2018 | 31/12/2017 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 30/09/2023 | 26/10/2022 | 26/10/2022 | 26/10/2022 | 30/08/2019 | 31/08/2018 |
| General meeting | 30/06/2023 | 30/06/2022 | 30/06/2021 | 30/06/2020 | 28/06/2019 | 29/06/2018 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
16 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2022 | 30/06/2023 | 30/09/2023 | Dutch | |
| Abridged model | 31/12/2021 | 30/06/2022 | 26/10/2022 | Dutch | |
| Abridged model | 31/12/2020 | 30/06/2021 | 26/10/2022 | Dutch | |
| Abridged model | 31/12/2019 | 30/06/2020 | 26/10/2022 | Dutch | |
| Abridged model | 31/12/2018 | 28/06/2019 | 30/08/2019 | Dutch | |
| Abridged model | 31/12/2017 | 29/06/2018 | 31/08/2018 | Dutch | |
| Abridged model | 31/12/2016 | 30/06/2017 | 31/08/2017 | Dutch | |
| Abridged model | 31/12/2014 | 30/06/2015 | 28/08/2015 | Dutch | |
| Abridged model | 31/12/2013 | 30/06/2014 | 19/08/2014 | Dutch | |
| Abridged model | 31/12/2012 | 28/06/2013 | 16/07/2013 | Dutch | |
| Abridged model | 31/12/2011 | 30/06/2012 | 31/08/2012 | Dutch | |
| Abridged model | 31/12/2010 | 30/06/2011 | 29/08/2011 | Dutch | |
| Abridged model | 31/12/2009 | 25/06/2010 | 23/07/2010 | Dutch | |
| Abridged model | 31/12/2008 | 26/06/2009 | 17/07/2009 | Dutch | |
| Abridged model | 31/12/2007 | 27/06/2008 | 25/07/2008 | Dutch | |
| Abridged model | 31/12/2006 | 30/06/2007 | 31/07/2007 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2022 · 1 active · 3 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Mandates02/06/2020BENAMING - ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM
- Mandates29/12/2015BENAMING - ONTSLAGEN - BENOEMINGEN - BOEKJAAR
- Other11/03/2005DIVERSEN
- Other25/06/2004RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2022Annual accounts 2022-81,1 k €↓
- 2021Annual accounts 2021670,7 €↑
- 2020Annual accounts 2020-86 k €↓
- 2019Annual accounts 2019-4 k €↓
- 2019Name changePhamily Pharma
- 2018Annual accounts 2018175,2 €↓
- 2017Annual accounts 201734,8 k €↑
- 2016Annual accounts 201612,1 k €↑
- 2016Name changeApotheek Esuna
- 2014Annual accounts 2014-2,4 k €↑
- 2013Annual accounts 2013-19,2 k €↓
- 2012Annual accounts 2012-976,1 €↑
- 2011Annual accounts 2011-7,8 k €↓
- 2010Annual accounts 201036,4 k €↑
- 2009Annual accounts 200932 k €↓
- 2008Annual accounts 200835,1 k €↑
- 2007Annual accounts 200724,2 k €↓
- 2006Annual accounts 200625,8 k €
- 2006Name changeApotheek Uyttersprot
- 17/06/2004IncorporationPrivate limited company